Literature DB >> 19430388

Vitreomacular traction syndrome: impact of anatomical configuration on anatomical and visual outcomes.

Kenan Sonmez1, Antonio Capone, Michael T Trese, George A Williams.   

Abstract

PURPOSE: To evaluate the relationship between preoperative structure and surgical outcome in eyes with macular edema caused by vitreomacular traction (VMT).
METHODS: A retrospective review of 24 eyes of 24 patients with macular edema due to VMT who underwent vitrectomy to relieve macular traction is presented. The diagnosis of VMT was based on findings of clinical examination and optical coherence tomography (OCT). Preoperative and postoperative best-corrected visual acuity was converted to logarithm of the minimal angle of resolution visual acuity for analysis. Patients with a minimum of 6 months of follow-up were included.
RESULTS: Eyes were categorized into one of the three groups based on the relationship of the posterior hyaloid to the retina: Group 1 (11 eyes) had focal vitreofoveal hyaloidal attachment with perifoveal separation; Group 2 (6 eyes) had vitreoretinal hyaloidal attachment to the macula and papillomacular bundle; and Group 3 (7 eyes) had broad vitreofoveal attachment with a fine epiretinal membrane over the posterior pole. Mean postoperative follow-up was 9.8 months (range, 6-15 months). Twenty-one eyes (87.5%) had at least 1 line of improvement in visual acuity (logMAR). Improvement in vision was significantly greater in the eyes in Group 1 (2.82 +/- 1.47 lines) than in those in Group 2 (0.83 +/- 1.17 lines; P = 0.004) or Group 3 (1.29 +/- 0.49 lines; P = 0.036). Visual outcome correlated with symptom duration (P = 0.024), VMT category (Group 1, 2, or 3; P = 0.013), and preoperative central macular thickness (CMT) by OCT (P = 0.007). A decrease in mean CMT was also significantly correlated with VMT configuration (Group 1, 2, or 3; P = 0.041).
CONCLUSIONS: Visual outcome after vitrectomy for VMT is correlated with preoperative vitreomacular structure, duration of symptoms, and preoperative CMT.

Entities:  

Mesh:

Year:  2008        PMID: 19430388     DOI: 10.1097/IAE.0b013e31817b6b0f

Source DB:  PubMed          Journal:  Retina        ISSN: 0275-004X            Impact factor:   4.256


  24 in total

1.  The design and validation of an optical coherence tomography-based classification system for focal vitreomacular traction.

Authors:  D H W Steel; L Downey; K Greiner; H Heimann; T L Jackson; Z Koshy; D A H Laidlaw; L Wickham; Y Yang
Journal:  Eye (Lond)       Date:  2016-01-15       Impact factor: 3.775

2.  [Ocriplasmin as a treatment option for symptomatic vitreomacular traction with and without macular hole. First clinical experiences].

Authors:  M Maier; S Abraham; C Frank; N Feucht; C P Lohmann
Journal:  Ophthalmologe       Date:  2015-12       Impact factor: 1.059

3.  Foveal Abnormality associated with epiretinal Tissue of medium reflectivity and Increased blue-light fundus Autofluorescence Signal (FATIAS).

Authors:  Roberto dell'Omo; Serena De Turris; Ciro Costagliola; Gianni Virgili; Ricarda G Schumann; Matteo Cereda; Isabella D'Agostino; Ermanno dell'Omo; Ferdinando Bottoni
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2019-09-07       Impact factor: 3.117

4.  The Charles Schepens Lecture: Management Options for Vitreomacular Traction: Use an Individualized Approach.

Authors:  Harry W Flynn; Nidhi Relhan
Journal:  Ophthalmol Retina       Date:  2017 Jan-Feb

Review 5.  Ocriplasmin for symptomatic vitreomacular adhesion.

Authors:  James E Neffendorf; Varo Kirthi; Edward Pringle; Timothy L Jackson
Journal:  Cochrane Database Syst Rev       Date:  2017-10-17

6.  Partial-thickness macular hole in vitreomacular traction syndrome: a case report and review of the literature.

Authors:  Niranjan Kumar; Jamal Al Kandari; Khalid Al Sabti; Vivek B Wani
Journal:  J Med Case Rep       Date:  2010-01-13

7.  Classifications of vitreomacular traction syndrome: diameter vs morphology.

Authors:  J Bottós; J Elizalde; E B Rodrigues; M Farah; M Maia
Journal:  Eye (Lond)       Date:  2014-07-04       Impact factor: 3.775

8.  Spectral domain optical coherence tomography in the diagnosis and management of vitreoretinal interface pathologies.

Authors:  Yoreh Barak; Mark A Ihnen; Shlomit Schaal
Journal:  J Ophthalmol       Date:  2012-06-04       Impact factor: 1.909

9.  Vitreomacular traction syndrome.

Authors:  Juliana Bottós; Javier Elizalde; J Fernando Arevalo; Eduardo B Rodrigues; Maurício Maia
Journal:  J Ophthalmic Vis Res       Date:  2012-04

10.  Ten Years of Severe Vitreomacular Traction Syndrome without Functional Damage Demonstrated by Optical Coherence Tomography.

Authors:  Michele Reibaldi; Teresio Avitabile; Maurizio Giacinto Uva; Francesco Occhipinti; Mario Toro; Marco Zagari; Andrea Russo
Journal:  Case Rep Ophthalmol Med       Date:  2011-09-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.